Why Biogen Stock Was a Winner on Wednesday
Source: Motley Fool
2026-04-29 20:06:53 ET
Prominent biotech Biogen (NASDAQ: BIIB) loomed large on the stock market on Wednesday. It published its latest set of quarterly earnings, and investors greeted the estimates-beating numbers by piling into the stock, despite a notable guidance cut. By the end of the trading day, Biogen's shares had gained 6%.
Biogen's total revenue for the first quarter of 2026 was $2.48 billion, up 2% year over year. This was sufficient to top the consensus prognosticator forecast of $2.25 billion.
Image source: Getty Images.
Apellis Pharmaceuticals Inc.
NASDAQ: APLS
APLS Trading
-0.01% G/L:
$41.04 Last:
5,223,027 Volume:
$41.05 Open:
APLS Latest News
May 07, 2026 06:01:00 pm
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600
APLS Stock Data
$2,869,591,944
89,501,409
1.5%
87
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
